VZ insider trading

Latest SEC Form 4 filings by VZ officers, directors and 10% owners.

Showing the last 30 days. 96 older filings are PRO.See full history →

Open-market buys (0)

No open-market insider buys in recent VZ filings.

Malady Kyle
EVP and Group CEO-VZ Business
$47.3K
Open-market sale · 1,100 sh @ $43.00
Traded 2026-10-27 · Filed 2026-10-28
Malady Kyle
EVP and Group CEO-VZ Business
$48.9K
Open-market sale · 1,100 sh @ $44.48
Traded 2026-10-20 · Filed 2026-10-21
Malady Kyle
EVP and Group CEO-VZ Business
$47.2K
Open-market sale · 1,100 sh @ $42.93
Traded 2026-10-13 · Filed 2026-10-14
Malady Kyle
EVP and Group CEO-VZ Business
$50.3K
Open-market sale · 1,100 sh @ $45.75
Traded 2026-10-06 · Filed 2026-10-07

Insider	Transaction	Shares	Price	Value	Traded	Filed
Malady Kyle EVP and Group CEO-VZ Business	Open-market sale	1,100	$43.00	$47.3K	2026-10-27	2026-10-28
Malady Kyle EVP and Group CEO-VZ Business	Open-market sale	1,100	$44.48	$48.9K	2026-10-20	2026-10-21
Malady Kyle EVP and Group CEO-VZ Business	Open-market sale	1,100	$42.93	$47.2K	2026-10-13	2026-10-14
Malady Kyle EVP and Group CEO-VZ Business	Open-market sale	1,100	$45.75	$50.3K	2026-10-06	2026-10-07

Source: SEC Form 4 filings. For education and research only. Not financial advice.